JORDAN GARCIA: Open Payments
NPI 1447867411 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 16 payments from 9 companies in 2025. Trend: 2023 $665 · 2024 $329 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| Impulse Dynamics (USA) Inc. | 1 | $168 |
| Novartis Pharmaceuticals Corporation | 5 | $137 |
| Abbott Laboratories | 3 | $83 |
| Edwards Lifesciences Corporation | 1 | $50 |
| Amgen Inc. | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: Optimizer, LEQVIO, CARDIOMEMS, PASCAL, LIVTENCITY, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, WAINUA, Attruby.
Industry payments across TX — which companies pay providers there.
